GGZPX
Price
$23.83
Change
+$0.16 (+0.68%)
Updated
Aug 8 closing price
Net Assets
456.52M
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

GGZPX vs VSTSX

Header iconGGZPX vs VSTSX Comparison
Open Charts GGZPX vs VSTSXBanner chart's image
Goldman Sachs Enhanced U.S. Equity P
Price$23.83
Change+$0.16 (+0.68%)
VolumeN/A
Net Assets456.52M
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
GGZPX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGZPX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGZPX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. GGZPX (457M). VSTSX pays higher dividends than GGZPX: VSTSX (1.20) vs GGZPX (0.54). GGZPX was incepted earlier than VSTSX: GGZPX (7 years) vs VSTSX (9 years). GGZPX (0.88) is less costly to investors than VSTSX (0.01). GGZPX is a more actively managed with annual turnover of: 79.00 vs. VSTSX (2.00). GGZPX has a lower initial minimum investment than VSTSX: GGZPX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 19.70 vs. GGZPX (16.73). VSTSX return over 5 years is better than : 85.11 vs. GGZPX (69.89).
GGZPXVSTSXGGZPX / VSTSX
Total Expense Ratio0.560.015,600%
Annual Report Gross Expense Ratio0.880.018,800%
Fund Existence7 years9 years-
Gain YTD6.4318.08880%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets457M1.91T0%
Annual Yield % from dividends0.541.2045%
Returns for 1 year16.7319.7085%
Returns for 3 years51.5052.0599%
Returns for 5 years69.8985.1182%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited